# Eurofins Amatsi Analytics - Inspection Records

Source: https://www.keypedia.com/companies/eurofins-amatsi-analytics/b634a442-c268-4779-920a-c50afd3e3af2

> Inspection records and compliance data for Eurofins Amatsi Analytics in Fontenilles, None. Access full analysis and detailed observations.

---

## Details

- Name: Eurofins Amatsi Analytics
- FEI Number: 3006118993
- City: Fontenilles
- State: None
- Country Name: France
- Address Line 1: Parc De Genibrat, 9 Avenue Claude Chappe
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1224183 - Eurofins Amatsi Analytics - 2023-11-03](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/aed3d852-5c11-41b6-a617-8bef1b4eb2c9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2023
- [FDA Inspection 1174252 - Eurofins Amatsi Analytics - 2021-08-05](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/c2c30371-9c6b-4491-84f9-1e1abc994c96) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 5, 2021
- [FDA Inspection 990192 - Eurofins Amatsi Analytics - 2016-09-28](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/c3888bc8-654f-4da0-948b-86d7417466d3) — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2016
- [FDA Inspection 865532 - Eurofins Amatsi Analytics - 2014-02-04](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/0f69c990-59ff-4653-9444-b854e608e828) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2014
- [FDA Inspection 865532 - Eurofins Amatsi Analytics - 2014-02-04](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/b6176a67-e8d6-48d1-888e-07208daeb0fd) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2014
- [FDA Inspection 706532 - Eurofins Amatsi Analytics - 2010-10-08](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/211b0935-fd55-4289-b278-be29043d9eb2) — classification: No Action Indicated (NAI), source: FDA, date: October 8, 2010
- [FDA Inspection 706532 - Eurofins Amatsi Analytics - 2010-10-08](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/ca462167-b1c1-4c90-aa35-ff2f694a06f4) — classification: No Action Indicated (NAI), source: FDA, date: October 8, 2010

## Related Companies

- [Fougera Pharmaceuticals  Inc.](https://www.keypedia.com/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b)
- [Particle Technology Group, LLC](https://www.keypedia.com/companies/particle-technology-group-llc/739b37e7-35ae-45aa-a515-a9d4d01fccb7)
- [Element Materials Technology Pharma USA LLC](https://www.keypedia.com/companies/element-materials-technology-pharma-usa-llc/d40408f6-37dd-44fb-8760-20aa927a8e8c)
- [QualTech Laboratories, Inc.](https://www.keypedia.com/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/9e5e908d-150e-4cb7-9d39-ab0eef6c4c0e)
- [R.D. Laboratories Inc.](https://www.keypedia.com/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [LabCorp Early Development Laboratories Limited.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad)
- [Quinta Analytica s.r.o.](https://www.keypedia.com/companies/quinta-analytica-sro/f26231ff-818d-4ba0-b952-72115b356982)
- [SGS Institut Fresenius GmbH](https://www.keypedia.com/companies/sgs-institut-fresenius-gmbh/9053e3ca-148d-4280-ac0d-789a34084eb8)
- [Bionique Testing Laboratories LLC](https://www.keypedia.com/companies/bionique-testing-laboratories-llc/5ff35d77-a641-4c19-be01-51977e5fa9da)